系统性硬化症临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 系统性硬化症（国际通用名 systemic sclerosis）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖硬皮病等说法。
正在招募的系统性硬化症新药试验
Open Label Treprostinil Raynaud's Study
IV 期招募中美国NCT07112183Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
不适用招募中法国NCT06599411Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
不适用招募中中国NCT07470151Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
早期 I 期招募中中国NCT07246096Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
不适用招募中Turkey (Türkiye)NCT07182981The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
不适用招募中美国NCT06675344Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis
I 期 / II 期招募中加拿大NCT04356287Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
II 期招募中美国NCT03844061Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
不适用招募中中国NCT06614270the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases
早期 I 期招募中中国NCT07339540A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
I 期招募中中国NCT07413341CAR-T Cells Therapy for Patients With Autoimmune Diseases
不适用招募中中国NCT07052565
系统性硬化症试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。